Signature Projects 2006-2017

For a leading pharmaceutical company: Supported CMO in developing a medical strategy and led large-scale project to sharpen all aspects of the medical organization.

For a leading life sciences company: Led effort to identify best practice and opportunities in building innovation hubs. Developed framework to priorities innovation hot-spot locations for their businesses.

For a leading global food company: Supported strategy team in developing a global forecast for the vegetable oil and fats market to kick-start strategy development in that sector.

For a top-10 pharmaceutical company: Optimized the clinical trial footprint with a particular focus on Emerging Markets in order to increase overall portfolio value.

For a top-10 pharmaceutical company: Developed an optimal price-/rebate strategy  for a key product in the German market.

For a top-10 life-science company: Formulated 3-year strategic plan for a new personalized medicine business unit.

For the generics unit of a top-10 pharmaceutical company: Facilitated implementation of and end-to-end supply chain process “playbook” with global leadership team.

For a top-10 generics company: Developed and implemented a tech ops benchmarking tool and management system for a large global production network, highlighting measures for substantial productivity gains.

For a top-10 pharmaceutical company: Optimized the promotional mix for a blockbuster product in a key market leading to a re-alignment of marketing efforts and budget.

For the German organization of a top-10 pharmaceutical company: Re-designed the field force organization and facilitated development and prioritization of new marketing programs.

For a leading pharmaceutical company: Developed a cooperative value-added approach between payor and our client with a focus on management of high-cost patients (Cooperation with Meier-Consulting).

For a top-5  global manufacturer of cardiac devices: Developed business plan and market entry strategy for the launch of a sales subsidiary in China. (Cooperation with Meier-Consulting).

For a leading specialty pharmaceutical company: Developed market forecast tool for a key ID product. (Cooperation with Meier-Consulting).